Director's Dealing • Mar 12, 2024
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 5640G
Persimmon PLC
12 March 2024
12 March 2024
Persimmon Plc (the "Company")
Director/PDMR Shareholding
On 12 March 2024 Dean Finch, Group Chief Executive, purchased 7,621 shares in the Company at a price of £13.15 per share.
Following this transaction, Dean Finch holds 24,078 shares in the Company.
The below notification is made in accordance with the requirements of article 19.3 of the UK Market Abuse Regulation.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
| a) | Name | Dean Finch | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Group Chief Executive | |||
| b) | Initial notification /Amendment | Initial notification | |||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | Persimmon Plc | |||
| b) | LEI | 213800XI72Y57UWN6F31 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a) | Description of the financial instrument, type of instrument | Ordinary shares of 10p each | |||
| Identification code | GB0006825383 | ||||
| b) | Nature of the transaction | Purchase of shares | |||
| c) | Price(s) and volume(s) | ||||
| Price(s) | Volume(s) | ||||
| £13.15 | 7,621 | ||||
| d) | Aggregated information | ||||
| - Aggregated volume | N/A Single transaction | ||||
| - Price | N/A Single transaction | ||||
| e) | Date of the transaction | 12/03/2024 | |||
| f) | Place of the transaction | London Stock Exchange (XLON), Main Market |
Tracy Davison
Company Secretary
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHEADDAFDXLEFA
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.